Teduglutide
Brand name: Gattex
Rank #179 of 500 drugs by total cost
$88.4M
Total Cost
1,758
Total Claims
$88.4M
Total Cost
104
Prescribers
$50K
Cost per Claim
11
Beneficiaries
1,825
30-Day Fills
$850K
Avg Cost/Provider
17
Avg Claims/Provider
About Teduglutide
Teduglutide (sold as Gattex) was prescribed 1,758 times by 104 Medicare Part D providers in 2023, costing the program $88.4M. At $50K per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 176 | Ixazomib Citrate (Ninlaro) | $89.0M | 6,901 |
| 177 | Lamotrigine (Lamotrigine) | $89.0M | 1,603,798 |
| 178 | Insulin Aspart Prot/Insuln Asp (Novolog Mix 70-30 Flexpen) | $88.8M | 79,814 |
| 179 | Teduglutide (Gattex) | $88.4M | 1,758 |
| 180 | Galcanezumab-Gnlm (Emgality Pen) | $87.0M | 101,221 |
| 181 | Imatinib Mesylate (Imatinib Mesylate) | $85.0M | 40,908 |
| 182 | Clopidogrel Bisulfate (Clopidogrel) | $84.7M | 5,428,304 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology